dn after td dna. but think of it as a template. the gene itself cannot be patented. the procedures they used cannot be patented. but when you have a gene, you need to create a replica of it with the junk taken out so to speak. and if that template that they say can be patented. now, let me just get to the next point because it's the important point. other companies can also create their own template of this, as well. they can figure out a way to copy these sort of dna strand that make up the gene and get rid of the junk and create their own template and then it wouldn't be the same that myriad has and that's why you'll probably see increased competition and other testing options become available because other companies will do this. >> and that brings me to my next